Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 97

1.

Serum (1->3)-β-D-glucan measurement in coccidioidomycosis.

Thompson GR 3rd, Bays DJ, Johnson SM, Cohen SH, Pappagianis D, Finkelman MA.

J Clin Microbiol. 2012 Sep;50(9):3060-2. doi: 10.1128/JCM.00631-12. Epub 2012 Jun 12.

2.

Reappraisal of the serum (1-->3)-beta-D-glucan assay for the diagnosis of invasive fungal infections--a study based on autopsy cases from 6 years.

Obayashi T, Negishi K, Suzuki T, Funata N.

Clin Infect Dis. 2008 Jun 15;46(12):1864-70. doi: 10.1086/588295. Erratum in: Clin Infect Dis. 2008 Dec 15;47(12):1611.

PMID:
18462174
3.

Multicenter clinical evaluation of the (1-->3) beta-D-glucan assay as an aid to diagnosis of fungal infections in humans.

Ostrosky-Zeichner L, Alexander BD, Kett DH, Vazquez J, Pappas PG, Saeki F, Ketchum PA, Wingard J, Schiff R, Tamura H, Finkelman MA, Rex JH.

Clin Infect Dis. 2005 Sep 1;41(5):654-9. Epub 2005 Jul 21.

PMID:
16080087
4.

[Utility of galactomannan enzyme immunoassay and (1,3)beta-D-glucan assay in invasive fungal infection].

Yu J, Li RY, Gao LJ, Lu QY, Wang XH.

Zhonghua Yi Xue Za Zhi. 2010 Feb 9;90(6):371-4. Chinese.

PMID:
20367931
5.

Positive (1-3) B-d-glucan and cross reactivity of fungal assays in coccidioidomycosis.

Zangeneh TT, Malo J, Luraschi-Monjagatta C, Hage CA, Wheat LJ, Strawter C, Klotz SA, Knox KS.

Med Mycol. 2015 Feb 1;53(2):171-3. doi: 10.1093/mmy/myu077. Epub 2014 Dec 24.

PMID:
25541557
6.

[Problems and recent advances in measurement of (1-->3)-beta-D-glucan].

Yoshida K, Shoji H, Niki Y.

Nihon Ishinkin Gakkai Zasshi. 2008;49(2):75-80. Review. Japanese.

7.

Invasive fungal infections and (1,3)-beta-D-glucan serum concentrations in long-term intensive care patients.

Presterl E, Parschalk B, Bauer E, Lassnigg A, Hajdu S, Graninger W.

Int J Infect Dis. 2009 Nov;13(6):707-12. doi: 10.1016/j.ijid.2008.10.013. Epub 2009 Jan 20.

9.

Beta-D-glucan as a diagnostic adjunct for invasive fungal infections: validation, cutoff development, and performance in patients with acute myelogenous leukemia and myelodysplastic syndrome.

Odabasi Z, Mattiuzzi G, Estey E, Kantarjian H, Saeki F, Ridge RJ, Ketchum PA, Finkelman MA, Rex JH, Ostrosky-Zeichner L.

Clin Infect Dis. 2004 Jul 15;39(2):199-205. Epub 2004 Jun 28.

PMID:
15307029
10.

(1-->3) beta -D-glucan assay in the diagnosis of invasive fungal infections.

Upton A, Leisenring W, Marr KA.

Clin Infect Dis. 2006 Apr 1;42(7):1054-6; author reply 1056. No abstract available.

PMID:
16511777
11.

[Detection of 1,3-beta-D glucan for diagnosis of invasive fungal infections in hematooncological patients: usefulness for screening of invasive mycosis and for confirmation of galactomannan positive results].

Rácil Z, Kocmanová I, Weinbergerová B, Winterová J, Lengerová M, Hrncírová K, Mayer J.

Klin Mikrobiol Infekc Lek. 2009 Apr;15(2):48-57. Czech.

PMID:
19488961
12.

A systematic review and meta-analysis of diagnostic accuracy of serum 1,3-β-D-glucan for invasive fungal infection: Focus on cutoff levels.

He S, Hang JP, Zhang L, Wang F, Zhang DC, Gong FH.

J Microbiol Immunol Infect. 2015 Aug;48(4):351-61. doi: 10.1016/j.jmii.2014.06.009. Epub 2014 Jul 28. Review.

13.

The (1,3){beta}-D-glucan test as an aid to early diagnosis of invasive fungal infections following lung transplantation.

Alexander BD, Smith PB, Davis RD, Perfect JR, Reller LB.

J Clin Microbiol. 2010 Nov;48(11):4083-8. doi: 10.1128/JCM.01183-10. Epub 2010 Aug 18.

14.

[The diagnostic value of detecting plasma 1, 3-beta-D-glucan for invasive fungal infections].

Lü PH, Zhao BL, Shi Y, Wen YT.

Zhonghua Jie He He Hu Xi Za Zhi. 2007 Jan;30(1):31-4. Chinese.

PMID:
17326970
15.

Clinical viability of Fungitell, a new (1→3)-β-D: -glucan measurement kit, for diagnosis of invasive fungal infection, and comparison with other kits available in Japan.

Yoshida K, Shoji H, Takuma T, Niki Y.

J Infect Chemother. 2011 Aug;17(4):473-7. doi: 10.1007/s10156-010-0198-6. Epub 2011 Jan 6.

PMID:
21210174
16.

Beta-D-glucan detection as a diagnostic test for invasive aspergillosis in immunocompromised critically ill patients with symptoms of respiratory infection: an autopsy-based study.

De Vlieger G, Lagrou K, Maertens J, Verbeken E, Meersseman W, Van Wijngaerden E.

J Clin Microbiol. 2011 Nov;49(11):3783-7. doi: 10.1128/JCM.00879-11. Epub 2011 Aug 31.

17.

What should be the optimal cut-off of serum 1,3-β-D-glucan for the detection of invasive pulmonary aspergillosis in patients with haematological malignancies?

Metan G, Koç AN, Atalay A, Kaynar LG, Ozturk A, Alp E, Eser B.

Scand J Infect Dis. 2012 May;44(5):330-6. doi: 10.3109/00365548.2011.638319. Epub 2011 Dec 21.

PMID:
22188426
18.

Cerebrospinal Fluid (1,3)-Beta-d-Glucan Testing Is Useful in Diagnosis of Coccidioidal Meningitis.

Stevens DA, Zhang Y, Finkelman MA, Pappagianis D, Clemons KV, Martinez M.

J Clin Microbiol. 2016 Nov;54(11):2707-2710. Epub 2016 Aug 24.

19.

Assessment of the clinical utility of serial beta-D-glucan concentrations in patients with persistent neutropenic fever.

Ellis M, Al-Ramadi B, Finkelman M, Hedstrom U, Kristensen J, Ali-Zadeh H, Klingspor L.

J Med Microbiol. 2008 Mar;57(Pt 3):287-95. doi: 10.1099/jmm.0.47479-0.

PMID:
18287290
20.

Diagnosis of invasive fungal disease using serum (1→3)-β-D-glucan: a bivariate meta-analysis.

Lu Y, Chen YQ, Guo YL, Qin SM, Wu C, Wang K.

Intern Med. 2011;50(22):2783-91. Epub 2011 Nov 15.

Supplemental Content

Support Center